Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Panacea Biotec Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Total Current Liabilities
â‚ą3.3B
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Total Current Liabilities
â‚ą990.5m
CAGR 3-Years
5%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Total Current Liabilities
â‚ą109.6m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Total Current Liabilities
â‚ą126.1m
CAGR 3-Years
-6%
CAGR 5-Years
-26%
CAGR 10-Years
-16%
Hester Biosciences Ltd
NSE:HESTERBIO
Total Current Liabilities
â‚ą1.3B
CAGR 3-Years
25%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Total Current Liabilities
â‚ą153.6B
CAGR 3-Years
56%
CAGR 5-Years
36%
CAGR 10-Years
27%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Total Current Liabilities?
Total Current Liabilities
3.3B INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Total Current Liabilities amounts to 3.3B INR.

What is Panacea Biotec Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-4%

Over the last year, the Total Current Liabilities growth was -1%. The average annual Total Current Liabilities growth rates for Panacea Biotec Ltd have been -17% over the past three years , -4% over the past five years .

Back to Top